Medical Condition News

RSS

Injection technique provides pain relief following knee replacement surgery

It's estimated that more than half of adults in the United States diagnosed with knee osteoarthritis will undergo knee replacement surgery.

22 Dec 2014

Mexican study shows mobility can be restored in patients with Parkinson's disease

Mexican scientists demonstrated experimentally, with adult rats, that mobility can be restored in patients with Parkinson's disease, the major degenerative disease of the motor system worldwide.

22 Dec 2014

Researchers devise new technique to understand how neutrophils move in bodily tissues

Neutrophils, a type of white blood cell, are the immune system's all-terrain vehicles. The cells are recruited to fight infections or injury in any tissue or organ in the body despite differences in the cellular and biochemical composition.

22 Dec 2014

Can-Fite BioPharma begins dosing in CF102 Phase II liver cancer trial

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer and inflammatory diseases, today announced that it has dosed the first patient in a Phase II trial for the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer.

22 Dec 2014

Oncolytics Biotech submits Orphan Designation to EMA for treatment of ovarian, pancreatic cancers

Oncolytics Biotech Inc. ("Oncolytics") today announced that it has submitted applications for Orphan Designation to the European Medicines Agency ("EMA") for REOLYSIN® for the treatment of pancreatic and ovarian cancers.

22 Dec 2014

Keryx Biopharmaceuticals supplies AURYXIA tablets to wholesalers in US

Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) (the "Company") today announced it has begun shipping AURYXIA™ (ferric citrate) tablets to wholesalers in the U.S. Auryxia is approved for the control of serum phosphorus levels in patients with chronic kidney disease (CKD) on dialysis.

22 Dec 2014

Researchers identify new genetic anomalies in smoking-related lung cancers

Developing effective treatments for lung cancer has been challenging, in part because so many genetic mutations play a role in the disease.

22 Dec 2014

HeartCycle GEx: A new distance rehabilitation system for people affected by heart pathologies

A team of Spanish researchers of the Universitat Politècnica de València, the Universidad Politécnica de Madrid and the company Medtronic have participated in the development of a new distance heart rehabilitation system based on physical exercise routines for people affected by heart pathologies.

22 Dec 2014

New computational technique reveals genetic roots of autism, cancers

In the decade since the genome was sequenced in 2003, scientists and doctors have struggled to answer an all-consuming question: Which DNA mutations cause disease?

22 Dec 2014

Higher parental education can increase depression risk in black youth

An investigation into factors related to disparities of depression in young adults has found that higher parental education - which has a protective effect for white youth - can also increase the risk of depression for black youth.

22 Dec 2014

Ganciclovir drug resistance may occur more frequently in cystic fibrosis patients

A drug called ganciclovir is given to lung transplant patients to protect against a life-threatening virus that is common after transplantation.

22 Dec 2014

FDA approves Myriad’s BRACAnalysis CDx for use with ovarian cancer drug

Myriad Genetics, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for BRACAnalysis CDx to be used as the only companion diagnostic in conjunction with AstraZeneca’s drug Lynparza™ (olaparib).

22 Dec 2014

Novo Nordisk gets positive CHMP opinion for expanded use of Tresiba in children with diabetes

Novo Nordisk today announced that the Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for expanded use of Tresiba® (insulin degludec) in children and adolescents aged one to 17 years with diabetes.

From Novo Nordisk 22 Dec 2014

FDA approves intravenous administration of Erwinaze (asparaginase Erwinia chrysanthemi)

Jazz Pharmaceuticals plc today announced that the U.S. Food and Drug Administration approved the intravenous administration of Erwinaze (asparaginase Erwinia chrysanthemi). Erwinaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia (ALL) who have developed hypersensitivity to E. coli-derived asparaginase.

19 Dec 2014

Researchers say that misfiring of the brain's control system may underpin compulsions in OCD

Misfiring of the brain's control system might underpin compulsions in obsessive-compulsive disorder (OCD), according to researchers at the University of Cambridge, writing in the American Journal of Psychiatry.

19 Dec 2014

Scientists identify white blood cells that tumors use to suppress disease-fighting immune system

A study led by St. Jude Children's Research Hospital scientists has identified the population of white blood cells that tumors use to enhance growth and suppress the disease-fighting immune system.

19 Dec 2014

School-based obesity prevention efforts may influence weight status of parents

Parents of children involved in an elementary school-based community intervention to prevent obesity appear to share in its health benefits. A new analysis of Shape Up Somerville: Eat Smart Play Hard shows an association between being exposed to the intervention as a parent and a modest decrease in body mass index (BMI) compared to parents in two similar control communities.

19 Dec 2014

Only few older adults use apps to help manage Type 2 diabetes, says new study

Despite showing interest in web or mobile apps to help manage their Type 2 diabetes, only a small number of older adults actually use them, says a new study from the University of Waterloo. Approximately 2.2 million Canadians are living with Type 2 diabetes, 2 million of whom are age 50 or older.

19 Dec 2014

C3BS enrols 240th patient in CHART-1 European trial of C-Cure for treatment of congestive heart failure

Cardio3 BioSciences, a leader in the discovery and development of regenerative, protective and reconstructive therapies, announces today the enrolment of the 240th patient in its CHART-1 European trial for C-Cure, the first and only stem cell therapeutic using guided stem cells for the treatment of congestive heart failure.

19 Dec 2014

Mayo Clinic researchers correctly evaluate polyps using high-definition optical lenses

It may not be necessary for experienced gastroenterologists to send polyps they remove from a patient's colon to a pathologist for examination, according to a large study conducted by physician researchers at the Jacksonville campus of Mayo Clinic.

19 Dec 2014

Medical Condition News

Injection technique provides pain relief following knee replacement surgery

Mexican study shows mobility can be restored in patients with Parkinson's disease

Researchers devise new technique to understand how neutrophils move in bodily tissues

Can-Fite BioPharma begins dosing in CF102 Phase II liver cancer trial

Oncolytics Biotech submits Orphan Designation to EMA for treatment of ovarian, pancreatic cancers

Keryx Biopharmaceuticals supplies AURYXIA tablets to wholesalers in US

Researchers identify new genetic anomalies in smoking-related lung cancers

HeartCycle GEx: A new distance rehabilitation system for people affected by heart pathologies

New computational technique reveals genetic roots of autism, cancers

Higher parental education can increase depression risk in black youth

Ganciclovir drug resistance may occur more frequently in cystic fibrosis patients

FDA approves Myriad’s BRACAnalysis CDx for use with ovarian cancer drug

Novo Nordisk gets positive CHMP opinion for expanded use of Tresiba in children with diabetes

FDA approves intravenous administration of Erwinaze (asparaginase Erwinia chrysanthemi)

Researchers say that misfiring of the brain's control system may underpin compulsions in OCD

Scientists identify white blood cells that tumors use to suppress disease-fighting immune system

School-based obesity prevention efforts may influence weight status of parents

Only few older adults use apps to help manage Type 2 diabetes, says new study

C3BS enrols 240th patient in CHART-1 European trial of C-Cure for treatment of congestive heart failure

Mayo Clinic researchers correctly evaluate polyps using high-definition optical lenses

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News